Document Detail

Rational strategy for rubella vaccination.
MedLine Citation:
PMID:  6129376     Owner:  NLM     Status:  MEDLINE    
Current rubella vaccination programmes, devised when knowledge of vaccine characteristics was still incomplete, have not been fully successful in protecting those at maximum risk of the sequelae of rubella infection. Now that more is known of vaccine characteristics and the impact of the initially chosen strategies has been assessed, it is time to modify immunisation strategies, the priorities being first to protect women of childbearing age, and then to interrupt transmission of rubella.
A R Hinman; K J Bart; W A Orenstein; S R Preblud
Related Documents :
6355196 - Use of the direct haemolysis-in-gel test for rubella antibodies in the icelandic preven...
12078986 - Experimental challenge and clinical cases of bohle iridovirus (biv) in native australia...
16564116 - The mmr vaccination and autism controversy in united kingdom 1998-2005: inevitable comm...
12192166 - Pediatric sentinel surveillance of vaccine-preventable diseases in italy.
9839376 - Dioctahedral smectite neutralization activity of clostridium difficile and bacteroides ...
8850036 - Molecular epidemiologic analysis of japanese patients with molluscum contagiosum.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Lancet     Volume:  1     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1983 Jan 
Date Detail:
Created Date:  1983-02-14     Completed Date:  1983-02-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  39-40     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arthritis / etiology
Great Britain
Infant, Newborn
National Health Programs*
Rubella / congenital,  prevention & control*,  transmission
Rubella Vaccine* / adverse effects,  therapeutic use
United States
Reg. No./Substance:
0/Rubella Vaccine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Relation between metaplastic polyp and carcinoma of the colorectum.
Next Document:  Successful substitution of rectal metronidazole administration for intravenous use.